Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HCWB HCW Biologics Inc
- Stocks
- Healthcare
- NASDAQ: HCWB
Price (delayed)
$3.75
Market cap
$5.4M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$24.4
Enterprise value
$18.23M
Highlights
HCWB's EPS is up by 21% since the previous quarter and by 20% year-on-year
The net income is up by 18% since the previous quarter and by 10% year-on-year
HCW Biologics's equity has plunged by 198% YoY and by 26% from the previous quarter
HCW Biologics's quick ratio has shrunk by 90% YoY and by 78% QoQ
Key stats
What are the main financial stats of HCWB
Market
Valuations
Earnings
Shares outstanding
1.44M
Market cap
$5.4M
Enterprise value
$18.23M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
12.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.74
Revenue
$345,670
Gross profit
$345,670
Operating income
-$23.95M
Net income
-$24.75M
EBIT
-$23.87M
EBITDA
-$22.51M
Free cash flow
-$14.27M
Per share
Balance sheet
Liquidity
EPS
-$24.4
EPS diluted
-$24.4
Free cash flow per share
-$12.78
Book value per share
-$7.62
Revenue per share
$0.31
TBVPS
$23.53
Total assets
$26.29M
Total liabilities
$34.85M
Debt
$13.94M
Equity
-$8.56M
Working capital
-$25.25M
Debt to equity
-1.63
Current ratio
0.07
Quick ratio
0.04
Net debt/EBITDA
-0.57
Margins
Efficiency
Dividend
EBITDA margin
-6,510.8%
Gross margin
100%
Net margin
-7,160.8%
Operating margin
-6,929.1%
Return on assets
-90.1%
Return on equity
N/A
Return on invested capital
-226%
Return on capital employed
N/A
Return on sales
-6,904.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCWB stock price
How has the HCW Biologics stock price performed over time
Intraday
-5.42%
1 week
-14.19%
1 month
-51.49%
1 year
-85.58%
YTD
-78.98%
QTD
-5.42%
Financial performance
How have HCW Biologics's revenue and profit performed over time
Revenue
$345,670
Gross profit
$345,670
Operating income
-$23.95M
Net income
-$24.75M
Gross margin
100%
Net margin
-7,160.8%
HCWB's operating margin has plunged by 189% YoY and by 126% from the previous quarter
The company's net margin has shrunk by 129% QoQ
HCW Biologics's gross profit has plunged by 70% YoY and by 64% from the previous quarter
HCWB's revenue has dropped by 70% year-on-year and by 64% since the previous quarter
Price vs fundamentals
How does HCWB's price correlate with its fundamentals
Growth
What is HCW Biologics's growth rate over time
Valuation
What is HCW Biologics stock price valuation
P/E
N/A
P/B
N/A
P/S
12.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.74
HCWB's EPS is up by 21% since the previous quarter and by 20% year-on-year
HCW Biologics's equity has plunged by 198% YoY and by 26% from the previous quarter
HCWB's revenue has dropped by 70% year-on-year and by 64% since the previous quarter
HCWB's price to sales (P/S) is 45% less than its last 4 quarters average of 23.1
Efficiency
How efficient is HCW Biologics business performance
HCWB's ROS has dropped by 195% year-on-year and by 125% since the previous quarter
HCWB's return on invested capital has dropped by 114% year-on-year
The ROA is up by 14% QoQ but it is down by 10% YoY
Dividends
What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCWB.
Financial health
How did HCW Biologics financials performed over time
HCWB's total assets is 25% smaller than its total liabilities
HCW Biologics's quick ratio has shrunk by 90% YoY and by 78% QoQ
The company's current ratio has shrunk by 85% YoY and by 63% QoQ
HCW Biologics's equity has plunged by 198% YoY and by 26% from the previous quarter
The company's debt has surged by 68% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.